Benefits and Safety of Early Tirofiban in the Treatment of Patients with Acute Coronary Syndrome : a Prospective , Multicenter and Randomized controlled trial.
Phase of Trial: Phase IV
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Tirofiban (Primary)
- Indications Acute coronary syndromes; Myocardial infarction
- Focus Therapeutic Use
- Acronyms BESTOWAL
- 22 Nov 2013 Planned number of patients changed from 3000 to 852 as reported by Chinese Clinical Trial Register.
- 31 May 2013 Status changed from recruiting to completed as reported by Chinese Clinical Trial Register.
- 21 May 2012 Planned end date changed from 1 May 2012 to 31 May 2013 as reported by Chinese Clinical Trial Register.